Related Research Articles
Scientific misconduct is the violation of the standard codes of scholarly conduct and ethical behavior in the publication of professional scientific research.
In academic publishing, a preprint is a version of a scholarly or scientific paper that precedes formal peer review and publication in a peer-reviewed scholarly or scientific journal. The preprint may be available, often as a non-typeset version available free, before or after a paper is published in a journal.
The Lancet is a weekly peer-reviewed general medical journal and one of the oldest of its kind. It is also one of the world's highest-impact academic journals. It was founded in England in 1823.
The New England Journal of Medicine (NEJM) is a weekly medical journal published by the Massachusetts Medical Society. It is among the most prestigious peer-reviewed medical journals as well as the oldest continuously published one.
In journalism and public relations, a news embargo or press embargo is a request or requirement by a source that the information or news provided by that source not be published until a certain date or certain conditions have been met. They are often used by businesses making a product announcement, by medical journals, and by government officials announcing policy initiatives; the media is given advance knowledge of details being held secret so that reports can be prepared to coincide with the announcement date and yet still meet press time.
Arnold Seymour Relman — known as Bud Relman to intimates — was an American internist and professor of medicine and social medicine. He was editor of The New England Journal of Medicine (NEJM) from 1977 to 1991, where he instituted two important policies: one asking the popular press not to report on articles before publication and another requiring authors to disclose conflicts of interest. He wrote extensively on medical publishing and reform of the U.S. health care system, advocating non-profit delivery of single-payer health care. Relman ended his career as professor emeritus at Harvard Medical School in Boston, Massachusetts.
David M. Serwadda is a Ugandan physician, medical researcher, academic, public health specialist and medical administrator. Currently he is a Professor of Public Health at Makerere University School of Public Health, one of the schools of Makerere University College of Health Sciences, a semi-autonomous constituent college of Makerere University, the oldest university in Uganda. Serwadda is also a founding member of Accordia Global Health Foundation's Academic Alliance.
Ravgen Inc. is a privately owned biotech company founded by Chairman and C.E.O. Dr. Ravinder Dhallan. Ravgen Inc. is known for its research in the prenatal diagnostic field and its development of non-invasive prenatal diagnosis testing which was published in The Lancet, the Journal of the American Medical Association ., and the New England Journal of Medicine. These publications received worldwide press in The Times, The Washington Post, CNN Fortune Small Business, and The New York Times
Franz Joseph Ingelfinger was a German-American physician, researcher and journal editor. He served as Chief of Gastroenterology at Evans Memorial Department of Clinical Research, part of Boston University School of Medicine. He also served as Editor of the New England Journal of Medicine (NEJM) from 1967 to 1976. His work was influential in the field of science journalism.
Sir Alimuddin Zumla,, FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2023, for the sixth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.
Mandeep R. Mehra is The William Harvey Distinguished Chair in Advanced Cardiovascular Medicine and a professor of medicine at Harvard Medical School. He is the medical director of the Brigham Heart and Vascular Center in Boston, Massachusetts, and specializes in advanced heart failure, mechanical circulatory support and cardiac transplantation.
Oriol Mitjà i Villar is a Catalan-born Spanish researcher and consultant physician in internal medicine and infectious diseases with expertise in poverty-related tropical diseases. He has conducted research at the Lihir Medical Centre in Papua New Guinea since 2010 on new diagnostic and therapeutic tools to eradicate yaws. He was awarded the Princess of Girona Award in the scientific research category. Currently at the Germans Trias i Pujol Research Institute, Mitjà is conducting research on SARS-CoV-2 coronavirus disease (COVID-19) and strategies to control the infection at a community level.
Michele Barry is a professor of medicine. She became Stanford's inaugural Senior Associate Dean of global health in 2009 and started the Stanford Center for Innovation in Global Health in 2010. Prior to this, she was a professor at Yale, where she started the first refugee health clinic and homeless health mobile van project, for which she was awarded the Elm Ivy Mayor’s Award. She specializes in tropical medicine, emerging infectious diseases, women’s leadership in global health, and human and planetary health.
Jocalyn Clark is a Canadian Public Health Scientist and the International Editor of The BMJ, with responsibility for strategy and internationalising the journal's content, contributors and coverage. From 2016 to 2022, Jocalyn was an Executive Editor at The Lancet, where she led the Commentary section, coordinated peer review, and edited and delivered collections of articles and Commissions on topics such as maternal and child health, oral health, migration, end of life care and gender equity. She led the Lancet's project to advance women in science, medicine, and global health, #LancetWomen. She is also an Adjunct Professor of Medicine at the University of Toronto and an Honorary Associate Professor at the Institute for Global Health at UCL.
Surgisphere is an American healthcare analytics company established in 2008 by Sapan Desai. Originally a textbook marketing company, it came under scrutiny in May 2020 after it provided large datasets of COVID-19 patients that were subsequently found to be unreliable. The questionable data were used in studies published in The Lancet and The New England Journal of Medicine in May 2020, suggesting that COVID-19 patients on hydroxychloroquine had a "significantly higher risk of death". In light of these studies, the World Health Organization decided to temporarily halt global trials of the drug hydroxychloroquine to treat COVID-19. After the studies were retracted, the WHO trials were resumed and then discontinued shortly after.
Sapan Sharankishor Desai is an American physician, and the owner of Surgisphere, originally a textbook marketing company that claimed to provide large sets of medical data on COVID-19 patients. This data and the research using it has been discredited, and two papers Desai co-authored that used this data were retracted after being published in prominent medical journals.
The Randomised Evaluation of COVID-19 Therapy is a large-enrollment clinical trial of possible treatments for people in the United Kingdom admitted to hospital with severe COVID-19 infection. The trial was later expanded to Indonesia, Nepal and Vietnam. The trial has tested ten interventions on adults: eight repurposed drugs, one newly developed drug and convalescent plasma.
Peer Community in (PCI) is a non-profit scientific organization that offers an editorial process of open science by creating specific communities of researchers reviewing and recommending preprints in their field. Since 2021, a new journal, Peer Community Journal, publishes recommended preprints.
The Lancet letter was a statement made in support of scientists and medical professionals in China fighting the outbreak of COVID-19, and condemning theories suggesting that the virus does not have a natural origin, which it referred to as "conspiracy theories". The letter was published in The Lancet on February 19, 2020, and signed by 27 prominent scientists, gaining a further 20,000 signatures in a Change.org petition. The letter generated significant controversy over the alleged conflicts of interest of its authors, and the chilling effect it had on scientists proposing that the COVID-19 lab leak theory be investigated.
References
- ↑ Marshall, E (1998). "Franz Ingelfinger's Legacy Shaped Biology Publishing". Science . 282 (5390): 861–3, 865–7. doi: 10.1126/science.282.5390.861 . PMID 9841429.
- ↑ "Ingelfinger rule definition". Medicine.net. 13 June 2000. Retrieved 2011-08-20.
- ↑ Schachtman, NA (20 June 2014). "Selective Leaking — Breaking Ingelfinger's Rule". Schachtman Law Blog. Retrieved 2015-05-23.
- ↑ Lariviere, V; Gingras, Y (2009). "On the prevalence and scientific impact of duplicate publications in different scientific fields (1980-2007)". arXiv: 0906.4019 [physics.soc-ph].
- ↑ Heidary, Fatemeh; Gharebaghi, Reza (2021-05-31). "COVID-19 impact on research and publication ethics". Medical Hypothesis, Discovery & Innovation in Ophthalmology. 10 (1): 1–4. doi: 10.51329/mehdiophthal1414 . ISSN 2322-3219. PMC 10460218 . PMID 37641621. S2CID 236407601.
- ↑ Borgman, CL (2007). Scholarship in the digital age: information, infrastructure, and the Internet. MIT Press. p. 99. ISBN 978-0-262-02619-2.
- ↑ Angell, M; Kassirer, J (1991). "The Ingelfinger Rule Revisited". The New England Journal of Medicine . 325 (19): 1371–1373. doi: 10.1056/NEJM199111073251910 . PMID 1669838.
- ↑ Lewenstein, BV (1988). "It's Not Really the Relman Rule". ScienceWriters. 36 (2): 17–18.